Report Type : Therapy Reports
Report Category : Cardiovascular
Report Subcategory : Bacterial Endocarditis
Price : 2999.00
Date : December 2021
Bacterial Endocarditis : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Bacterial Endocarditis
Bacterial endocarditis is a condition in which bacterial infection occurred on inner layer of the heart muscle, caused by bacteria in the bloodstream spreading across the inner lining of the heart.

Top 10 Companies:
F. Hoffmann-La Roche Ltd
Pfizer Inc
Merck & Co Inc
GlaxoSmithKline Plc
Sanofi
Abbott Laboratories
Bristol-Myers Squibb Co
AstraZeneca Plc
Eli Lilly and Co
Novo Nordisk AS